• Mashup Score: 0

    Summary. A recent article analyzed paired cell-free DNA among patients with platinum-sensitive BRCA- or PALB2-mutated pancreatic cancer who received maintenance olaparib. Reversion mutations were linked with worse outcomes. These types of paired correlative studies are needed to improve our understanding of drug resistance and guide future clinical trials.See related article by Brown et al., p. xxxx

    Tweet Tweets with this article
    • "Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer" commentary by Dr @EricaTsangMD and Dr Gallinger on our (@KReissMD) recent paper in @CCR_AACR https://t.co/cUv4J1GDXl

  • Mashup Score: 10

    Erin Bange, Kerry Coughlin, Wenrui Li, Timothy Brown, Daniel Ragusano, Eesha Balar, Dhivya Arasappan, Michelle Nnaji, Elliot Kim, Corey Alban, Sindhuja Uppuluri, Lindsey Zinck, Donna Capozzi, Michael Josephs, Danielle Zubka, Roy Rosin, Mohan Balachandran, Lawrence Shulman, Carmen Guerra, Ronac Mamtani Memorial Sloan Kettering Cancer Center, Penn Abramson Cancer Center, University of Pennsylvania, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Perelman School of Medicine, University

    Tweet Tweets with this article
    • Text Interventions to Minimize Time Burden of Cancer Care (TIME). Come see our rapid oral abstract at @ASCO #ASCOQLTY23 @erin_bange @Ron_cology @kerrycoughlin @PC3Innovation https://t.co/5bfgfqayEJ

  • Mashup Score: 1

    In this issue of Blood, Brown et al show that novel therapy with intermediate- to high-dose nonsteroidal antiinflammatory drugs (NSAIDs) overcomes augmented inf

    Tweet Tweets with this article
    • So stoked to see a companion article with a legendary title from former @UTSWInternalMed @UTSWIMchief co-resident (now full fledged hematologist @bcmhouston ) @SSukumarMD ! @dhjutsw1 @DinoKazi https://t.co/UFzv3HmVt6